IP Library › Granted Patent US 11,707,459
Granted Patent B2
US 11,707,459 · App. 17/170,821 · Granted Jul 25, 2023

Method for treating nervous system injuries using boldine and analogs thereof

Inventors: Christopher Cardozo (Bronx, NY); Carlos A. Toro Chacon (Bronx, NY); Zachary Graham (Birmingham, AL); Wei Zhao (Bronx, NY); Juan C. Saez (Vina del Mar, CL)
Assignee: United States Government as Represented by the Department of Veterans Affairs
A61K31/47A61P25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,459
App. No.
17/170,821
Granted
Jul 25, 2023
Kind
B2
Abstract

Provided are methods of treating an injury to the nervous system in a subject comprising administering to the subject an effective amount of boldine, a boldine analog, or a pharmaceutically-acceptable salt thereof. Also provided are methods of improving voluntary muscle control and methods of treating neuropathic pain in a subject having an injury to the nervous system. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Claims (10)

1. A method of treating spinal cord injury (SCI) in a subject, comprising administering to the subject an effective amount of a compound represented by a formula:

or a pharmaceutically-acceptable salt thereof, thereby treating the SCI in the subject.

2. The method of claim 1 , wherein the compound is represented by the formula:

3. The method of claim 1 , wherein the compound is orally administered to the subject.

4. The method of claim 1 , wherein the compound intravenously administered to the subject.

5. The method of claim 1 , wherein the compound is administered up to 24 hours after the SCI.

6. A method of treating a SCI in a subject, the method comprising intravenously administering to the subject an effective amount of a compound having a structure represented by a formula:

or a pharmaceutically acceptable salt thereof,

wherein the compound is intravenously administered up to 24 hours after the SCI.

7. The method of claim 6 , wherein the compound is represented by the formula:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2021
From: CARDOZO, CHRISTOPHER; TORO-CHACON, CARLOS A.; GRAHAM, ZACHARY AARON; ZHAO, WEI
To: UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 057096/0190 →
Continuity (3)
Provisional Application 63043572 · Jun 24, 2020
Provisional Application 62971757 · Feb 7, 2020
Related Publication 20210251979A1 · Aug 19, 2021